cefuroxime has been researched along with Hearing Loss, Sensorineural in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare ceftriaxone with cefuroxime for the treatment of meningitis, we conducted a study in which 106 children with acute bacterial meningitis were randomly assigned to receive either ceftriaxone (100 mg per kilogram of body weight per day, administered intravenously once daily; n = 53) or cefuroxime (240 mg per kilogram per day, administered intravenously in four equal doses; n = 53)." | 9.06 | A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. ( Auckenthaler, R; Bernath, O; Cheseaux, JJ; Gianella-Borradori, A; Pfenninger, J; Schaad, UB; Suter, S; Wedgwood, J, 1990) |
| "To compare ceftriaxone with cefuroxime for the treatment of meningitis, we conducted a study in which 106 children with acute bacterial meningitis were randomly assigned to receive either ceftriaxone (100 mg per kilogram of body weight per day, administered intravenously once daily; n = 53) or cefuroxime (240 mg per kilogram per day, administered intravenously in four equal doses; n = 53)." | 5.06 | A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. ( Auckenthaler, R; Bernath, O; Cheseaux, JJ; Gianella-Borradori, A; Pfenninger, J; Schaad, UB; Suter, S; Wedgwood, J, 1990) |
| "Early treatment of profound bilateral sensorineural hearing loss with cochlear implantation has become routine, resulting in an increased proportion of children implanted at younger ages." | 1.39 | The management of acute mastoiditis in children with cochlear implants: saving the device. ( Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osborn, HA | 1 |
| Cushing, SL | 1 |
| Gordon, KA | 1 |
| James, AL | 1 |
| Papsin, BC | 1 |
| Stein, LK | 1 |
| Boyer, KM | 1 |
| Schaad, UB | 1 |
| Suter, S | 1 |
| Gianella-Borradori, A | 1 |
| Pfenninger, J | 1 |
| Auckenthaler, R | 1 |
| Bernath, O | 1 |
| Cheseaux, JJ | 1 |
| Wedgwood, J | 1 |
1 trial available for cefuroxime and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.
Topics: Adolescent; Bacterial Infections; Ceftriaxone; Cefuroxime; Cephalosporins; Cerebrospinal Fluid; Chil | 1990 |
2 other studies available for cefuroxime and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefu | 2013 |
Progress in the prevention of hearing loss in infants.
Topics: Ceftriaxone; Cefuroxime; Child, Preschool; Dexamethasone; Haemophilus influenzae; Hearing Disorders; | 1994 |